Equithrive® Announces Sponsorship of The Ridge at Wellington's 2016 Turf Tour
Wellington, Florida – Two equestrian industry pioneers, Olympian Nona Garson and Dr. Patrick Lawless of Equithrive®, recently joined forces to further develop Wellington’s winter equestrian season and bring their innovative ventures to equines and equestrians around the world. Equithrive, developer of the only clinically proven joint supplement, recently announced their sponsorship with The Ridge at Wellington’s 2016 Turf Tour, a unique show jumping circuit featuring all natural competition surfaces and a variety of exciting venues around Wellington.
“We are very proud to be sponsors of the 2016 Turf Tour,” said Patrick Lawless, PhD, founder of Equithrive. “Nona, through her vision of the Turf Tour, is clearly creating a superior environment for equestrians and their horses to compete, and that follows in the same vein as our mission at Equithrive. Our goal is to deliver the most advanced and scientifically proven products to riders so that their horses can reap optimum health benefits.” The collaboration between the Turf Tour and Equithrive will be mutually beneficial for both the growing show series and the equine supplement company, but the biggest benefit will be seen by the riders as they enjoy the 13-week show circuit and discover the incredible effects of Equithrive’s ground breaking Resveratrol therapy.
Equithrive’s dedication to research and development has resulted in a line of cutting edge supplements that feature Resveratrol, the healthy ingredient found in red wine. The company’s headline product, a joint supplement known as Equithrive® Joint, was the first purified Resveratrol product introduced into the equine market. Equithrive Joint has been scientifically proven to reduce inflammation and oxidative stress in performance horses, factors that negatively affect athletic performance, delay recovery, and damage joint tissue, which can lead to arthritis. Equithrive Joint is administered as a daily oral supplement to support continued joint health and optimum performance in horses and can be used during FEI-sanctioned competitions. It also has the added benefit that it can be used safely on a long-term daily basis without causing the negative gastrointestinal side effects associated with NSAID use.
Equithrive also manufactures a product that supports metabolic health in horses that are insulin resistant (IR) and prone to foundering. MetabarolTM, a higher dose Resveratrol product, was designed for horses suffering from Equine Metabolic Syndrome (EMS), which is characterized by insulin resistance (IR), foundering and obesity. Research performed at the University of Kentucky’s Gluck Equine Research Center demonstrated Metabarol’s capability to reduce inflammation and insulin levels in horses previously diagnosed with EMS. Metabarol is the only product in the equine market that has been scientifically proven to reduce high insulin levels, the leading cause of foundering, in horses that naturally have EMS. The Gluck Center Study was supported by the American Quarter Horse Association (AQHA).
Sold primarily by veterinarians and through referrals from vet clinics, Equithrive and Metabarol can also be purchased directly by horse owners and trainers. The product’s incredible benefits for horses rehabbing, overcoming injury, or managing chronic disease, such as arthritis or EMS, made it an obvious choice for veterinarians. Competition barns across the US are now increasingly adding Equithrive to their daily regimen to keep their horses in top form and to support continued joint health in their equestrian athletes. Metabarol is being used by veterinarians, horse owners and trainers to lower insulin levels in IR horses to reduce the risk of foundering.
Equithrive and Metabarol contain a proprietary form of Resveratrol named Resverasyn®. Resverasyn is a microencapsulated Resveratrol product that ensures Equithrive and Metabarol deliver therapeutic doses of Resveratrol throughout the body for maximal benefit. When not microencapsulated, Resveratrol has low bioavailability and is susceptible to breakdown with exposure to heat, light and moisture, which are characteristic of barn and tack room settings.
For more information on Equithrive, its product line, sponsored riders, and veterinary and patient testimonials, visit their website at www.Equithrive.com, follow them on Facebook, or call them directly at 866 721 1412.
Top of Page